Santhera Acquires Juvantia and Secures All Rights to JP-1730/Fipamezole

News   Aug 17, 2009

 
Santhera Acquires Juvantia and Secures All Rights to JP-1730/Fipamezole
 
 
 

RELATED ARTICLES

Cancer Cells’ Energy Source Blocked by Natural Compound

News

Researchers have not only untangled an unusual wiring system that cancer cells use for carbohydrate metabolism, but also identified a natural compound that appears to selectively shut down this system in laboratory studies.

READ MORE

Methane Hydrate Formation Studied Using Novel Microreactor

News

Researchers at the NYU Tandon School of Engineering are using a novel means of studying how methane and water form methane hydrate that allows them to examine discrete steps in the process faster and more efficiently.

READ MORE

Machine Learning to Increase the Pace of Brain Imaging Analysis

News

New approach could allow doctors or researchers to quickly identify the data they need, and then rapidly fill in the fine details, making the process faster and more accurate.

READ MORE

 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Proteomics & Metabolomics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE